Last Price
0.33
Today's Change
-0.01 (2.94%)
Day's Change
0.32 - 0.367
Trading Volume
552,478
Market Cap
16 Million
Shares Outstanding
51 Million
Avg Volume
11,310,938
Avg Price (50 Days)
0.37
Avg Price (200 Days)
1.29
PE Ratio
-0.04
EPS
-8.31
Earnings Announcement
12-Mar-2025
Previous Close
0.34
Open
0.34
Day's Range
0.32 - 0.3666
Year Range
0.22 - 2.63
Trading Volume
552,478
1 Day Change
-4.35%
5 Day Change
-12.04%
1 Month Change
8.40%
3 Month Change
-70.44%
6 Month Change
-81.20%
Ytd Change
-11.87%
1 Year Change
-80.41%
3 Year Change
-99.34%
5 Year Change
-99.63%
10 Year Change
-99.96%
Max Change
-100.00%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.